AARTI DRUGS LTD.
|
Market Cap.(`)
|
4139.09 Cr.
|
P/BV
|
3.24
|
Book Value (`)
|
139.96
|
|
52 Week High/Low ( ` )
|
635/312
|
FV/ML
|
10/1
|
P/E(X)
|
24.61
|
|
Book Closure
|
04/02/2025
|
EPS (`)
|
18.42
|
Div Yield (%)
|
0.22
|
(` in Crs.)
You can view the
Consolidated
Income Statement
for the last 5 years.
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR | AR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | | |
| | | | | | |
| INCOME | | | | | |
| Revenue From Operations [Net] | 2387.03 | 2508.87 | 2705.57 | 2488.65 | 2154.78 |
| Other Operating Revenues | 0.00 | 19.71 | 10.49 | 0.00 | 0.00 |
| Total Operating Revenues | 2387.03 | 2528.58 | 2716.05 | 2488.65 | 2154.78 |
| | | | | | |
| Other Income | 16.36 | 4.03 | 2.19 | 11.32 | 4.53 |
| Total Revenue | 2403.39 | 2532.61 | 2718.25 | 2499.96 | 2159.30 |
| | | | | | |
| EXPENSES | | | | | |
| Cost Of Materials Consumed | 1438.30 | 1571.98 | 1768.97 | 1666.36 | 1221.52 |
| Purchase Of Stock-In Trade | 84.34 | 80.23 | 121.29 | 108.57 | 111.24 |
| Operating And Direct Expenses | 0.00 | 346.28 | 334.09 | 295.98 | 233.43 |
| Changes In Inventories Of FG,WIP And Stock-In Trade | 19.46 | 25.51 | -1.75 | -86.08 | -11.72 |
| Employee Benefit Expenses | 112.10 | 102.34 | 92.02 | 82.81 | 80.50 |
| Finance Costs | 35.87 | 33.52 | 33.29 | 20.75 | 22.96 |
| Depreciation And Amortisation Expenses | 55.78 | 51.45 | 50.32 | 50.05 | 49.88 |
| Other Expenses | 445.77 | 85.77 | 95.83 | 91.58 | 82.71 |
| Total Expenses | 2191.62 | 2297.08 | 2494.07 | 2230.01 | 1790.52 |
| | | | | | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 211.77 | 235.53 | 224.18 | 269.96 | 368.79 |
| | | | | | |
| Exceptional Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.22 |
| Profit/Loss Before Tax | 211.77 | 235.53 | 224.18 | 269.96 | 369.01 |
| | | | | | |
| Tax Expenses-Continued Operations | | | | | |
| Current Tax | 43.67 | 59.56 | 58.86 | 69.74 | 93.00 |
| Less: MAT Credit Entitlement | 0.00 | 0.00 | 0.00 | 0.00 | -0.08 |
| Deferred Tax | 0.00 | 4.37 | -1.03 | -4.78 | -4.46 |
| Total Tax Expenses | 43.67 | 63.94 | 57.82 | 64.96 | 88.62 |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 168.10 | 171.59 | 166.36 | 205.00 | 280.40 |
| | | | | | |
| Profit/Loss From Continuing Operations | 168.10 | 171.59 | 166.36 | 205.00 | 280.40 |
| | | | | | |
| Profit/Loss For The Period | 168.10 | 171.59 | 166.36 | 205.00 | 280.40 |
| | | | | | |
| Minority Interest | 0.06 | -0.17 | -0.05 | 0.04 | 0.01 |
| Consolidated Profit/Loss After MI And Associates | 168.16 | 171.42 | 166.31 | 205.04 | 280.41 |
| | | | | | |
| OTHER INFORMATION | | | | | |
| | | | | | |
| EARNINGS PER SHARE | | | | | |
| Basic EPS (Rs.) | 18.35 | 18.56 | 17.97 | 22.12 | 30.09 |
| Diluted EPS (Rs.) | 18.35 | 18.56 | 17.97 | 22.12 | 30.09 |
| | | | | | |
| DIVIDEND AND DIVIDEND PERCENTAGE | | | | | |
| Equity Share Dividend | 0.00 | 9.19 | 9.26 | 9.26 | 23.30 |